AI.NYSEC3ai, INC

Form 4: C3.ai Director Executes Stock Transactions Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


A C3.ai director, Stephen M. Ward Jr., executed multiple stock transactions, including sales and option exercises, under a pre-established 10b5-1 trading plan.

Summary

  • Stephen M. Ward Jr., a director at C3.ai, engaged in several transactions involving the company's Class A Common Stock on December 9, 2024.
  • These transactions included the acquisition of 102,795 shares through option exercises at $4.68 per share, and 22,205 shares at $3.90 per share.
  • Additionally, 125,000 shares were sold at a weighted average price of $42, with prices ranging from $42.00 to $42.08.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on March 26, 2024.
  • The director also has stock options that vest quarterly, contingent on attending board meetings, with a provision for delayed vesting if attendance requirements are not met.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports routine stock transactions under a pre-established plan. There are no indications of significant positive or negative developments.

Positives

  • The director's stock transactions are part of a pre-planned trading strategy, which can be seen as a normal course of business.
  • The exercise of stock options indicates the director's belief in the company's long-term value.

Negatives

  • The sale of 125,000 shares by the director could be interpreted as a lack of confidence in the company's short-term prospects, although it is part of a pre-planned strategy.

Risks

  • The vesting of stock options is contingent on the director's attendance at board meetings, which introduces a potential risk of delayed vesting if attendance requirements are not met.
  • The market may react negatively to the sale of shares by a company director, even if it is part of a pre-planned strategy.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Management Comments

  • The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan dated March 26, 2024.

Industry Context

This type of filing is common for publicly traded companies and reflects the normal course of business for directors and officers who hold company stock and options. It is a routine disclosure required by the SEC.

Comparison to Industry Standards

  • The use of a 10b5-1 trading plan is a standard practice among corporate insiders to avoid accusations of insider trading.
  • The vesting schedule tied to board meeting attendance is a common mechanism to ensure director engagement and alignment with company goals.
  • The reported transaction prices are within the typical range for stock transactions of this nature.

Stakeholder Impact

  • The stock transactions may have a minor impact on the stock price, but the pre-planned nature of the transactions should mitigate any significant market reaction.
  • The vesting schedule tied to board meeting attendance ensures that the director remains engaged and aligned with the company's interests.

Key Dates

DateDescription
2019-10-17Commencement date for the quarterly vesting of stock options, contingent on board meeting attendance.
2024-03-26Date of the establishment of the Rule 10b5-1 trading plan.
2024-12-09Date of the reported stock transactions, including option exercises and share sales.
2024-12-11Date of the filing of the transaction report.
2028-11-27Date of full vesting of 22,205 shares.
2029-10-18Date of full vesting of 102,795 shares.

Keywords

C3.ai, stock transactions, Rule 10b5-1, stock options, insider trading, director, vesting, board meetings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.